SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-16-011428
Filing Date
2016-03-22
Accepted
2016-03-22 11:58:11
Documents
59
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2227816z10-k.htm 10-K 846298
2 EX-10.39 a2227816zex-10_39.htm EX-10.39 7540
3 EX-23.1 a2227816zex-23_1.htm EX-23.1 3009
4 EX-31.1 a2227816zex-31_1.htm EX-31.1 8311
5 EX-31.2 a2227816zex-31_2.htm EX-31.2 8372
6 EX-32.1 a2227816zex-32_1.htm EX-32.1 4721
7 EX-32.2 a2227816zex-32_2.htm EX-32.2 4778
14 G737701.JPG g737701.jpg GRAPHIC 72349
15 G366574.JPG g366574.jpg GRAPHIC 65285
16 G155739.JPG g155739.jpg GRAPHIC 42320
17 G999762.JPG g999762.jpg GRAPHIC 41715
  Complete submission text file 0001047469-16-011428.txt   3655980

Data Files

Seq Description Document Type Size
8 EX-101.INS dprx-20151231.xml EX-101.INS 556936
9 EX-101.SCH dprx-20151231.xsd EX-101.SCH 29780
10 EX-101.CAL dprx-20151231_cal.xml EX-101.CAL 30310
11 EX-101.DEF dprx-20151231_def.xml EX-101.DEF 97621
12 EX-101.LAB dprx-20151231_lab.xml EX-101.LAB 299927
13 EX-101.PRE dprx-20151231_pre.xml EX-101.PRE 206347
Mailing Address 14 WALL ST. SUITE 3D NEW YORK NY 10005
Business Address 14 WALL ST. SUITE 3D NEW YORK NY 10005 212-269-2834
Dipexium Pharmaceuticals, Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36351 | Film No.: 161520431
SIC: 2834 Pharmaceutical Preparations